Noriyuki Kasahara

8PUBLICATIONS
45CO-AUTHORS
Molecular targetsGene and molecular therapyImmunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 13, 2026
Mesenchymal stem cell-mediated delivery boosts the efficacy of suicide gene therapy based on retroviral replicating vectors in peritoneally disseminated cancer.

|Jun 20, 2025
Measles Oncolytic Virus as an Immunotherapy for Recurrent/Refractory Pediatric Medulloblastoma and Atypical Teratoid/Rhabdoid Tumor: Results from PNOC005.

Bohyeon Yu, Cassie Kline, Owen Hoare

|Aug 08, 2024
Interferon regulatory factor 8-driven reprogramming of the immune microenvironment enhances antitumor adaptive immunity and reduces immunosuppression in murine glioblastoma.

Megan Montoya, Sara A Collins, Pavlina Chuntova

|Jul 22, 2024
Therapeutic activity of retroviral replicating vector-mediated gene therapy in combination with anti-PD-1 antibody in a murine pancreatic cancer model.

Hiroki Niwa, Toru Nakamura, Hiroki Kushiya

|Mar 13, 2024
Targeted Suicide Gene Therapy with Retroviral Replicating Vectors for Experimental Canine Cancers.

Emiko Sonoda-Fukuda, Yuya Takeuchi, Nao Ogawa

|Oct 14, 2023
Retroviral Replicating Vectors Mediated Prodrug Activator Gene Therapy in a Gastric Cancer Model.

Hiroaki Fujino, Emiko Sonoda-Fukuda, Lisa Isoda

Pageof 2

Frequent Collaborators

3 joint publications

Shuji Kubo

2 joint publications

Kazuho Inoko

2 joint publications

Douglas J Jolly

2 joint publications

Toru Takarada